|
|
|
Arakawa, T., Niikura, T., Arisaka, F., and Kita, Y. (2008). Activity-dependent neurotrophic factor, ADNF, determines the structure characteristics of Colivelin, a fusion protein of ADNF9 and Humanin analog. J. Pept. Sci. 14, 631-636. Arakawa, T., Tsumoto, K., Kita, Y., Chang, B., and Ejima, D. (2007). Biotechnology applications of amino acids in protein purification and formulations. Amino Acids 33, 587-605. Arakawa, T., Kita, Y., and Timasheff, S. N. (2007). Protein precipitation and denaturation by dimethyl sulfoxide. Biophys. Chem. 131, 62-70. Arakawa, T., Philo, J. S., Ejima, D., Sato, H., and Tsumoto, K. (2007). Aggregation analysis of therapeutic proteins, part 3. Bioprocess International 5 (10), 52-70. [PDF] Arakawa, T., Takako, N., Hirohisa, T., Arisaka, F., and Kita, Y. (2007). Structure analysis of activity-dependent neurotrophic factor 9 by circular dichroism and sedimentation equilibrium. J. Mol. Neurosci. 33, 262-267. Arakawa, T., Ejima, D., Tsumoto, K., Obeyama, N., Tanaka, Y., Kita, Y., and Timasheff, S. N. (2007). Suppression of protein interactions by arginine: A proposed mechanism of the arginine effects. Biophys. Chem. 127, 1-8. Ishibashi, M., Tatsuda, S., Izutsu, K. I., Kumeda, K., Arakawa, T., and Tokunaga, M. (2007). A single Gly 114Arg mutation stabilizes the hexameric subunit assembly and changes the substrate specificity of halo-archaeal nucleoside diphosphate kinase. FEBS Lett. 581, 4073-4079. Arakawa, T., Ejima, D., Tsumoto, K., Ishibashi, M., and Tokunaga, M. (2007). Improved performance of column chromatography by arginine: Dye-affinity chromatography. Protein Express Purif. 52, 410-414. Heavner, G. A., Arakawa, T., Philo, J. S., Calmann, M. A., and Labrenz, S. (2007). Protein isolated from biopharmaceutical formulations cannot be used for comparative studies: Follow-up to "a case study using Epoetin Alfa from Epogen and EPREX". J. Pharm. Sci. 96, 3214-3225. Tsumoto, K., Ejima, D., Nagase, K., and Arakawa, T. (2007). Arginine improves protein elution in hydrophobic interaction chromatography - The cases of human interleukin-6 and activin-A. J. Chromatogr. A 1154, 81-86. Arakawa, T., Philo, J. S., Ejima, D., Tsumoto, K., and Arisaka, F. (2007). Aggregation analysis of therapeutic proteins, part 2. Bioprocess International 5 (4), 36-47. [PDF] Arakawa, T., Tsumoto, K., Ejima, D., Kita, Y., Yonezawa, Y., and Tokunaga, M. (2007). Induced binding of proteins by ammonium sulfate in affinity and ion-exchange column chromatography. J. Biochem. Biophys. Meth. 70, 493-498. Tsumoto, K., Ejima, D., Senczuk, A. M., Kita, Y., and Arakawa, T. (2007). Effects of salts on protein-surface interactions: applications for column chromatography. J. Pharm Sci. [e-pub ahead of print] Arakawa, T., Tsumoto, K., Ejima, D., Kita, Y., Yonezawa, Y., and Tokunaga, M. (2007). Induced binding of proteins by ammonium sulfate in affinity and ion-exchange column chromatography. J. Biochem. Biophys. Methods [e-pub ahead of print] Ejima, D., Tsumoto, K., and Arakawa, T. (2007). Improved column chromatography performance using arginine. Amer. Biotech. Lab. 25, 16-18. Arakawa, T., Ejima, D., Tsumoto, K., Obeyama, N., Tanaka, Y., Kita, Y., and Timasheff, S. N. (2007). Suppression of protein interactions by arginine: A proposed mechanism of the arginine effects. Biophys. Chem. 127, 1-8. Arakawa, T., Tsurnoto, K., Nagase, K., and Ejima, D. (2007). The effects of arginine on protein binding and elution in hydrophobic interaction and ion-exchange chromatography. Protein Express Purif. 54, 110-116. Ejima, D., Tsumoto, K., Fukada, H., Yumioka, R., Nagase, K., Arakawa, T., and Philo, J. S. (2007). Effects of acid exposure on the conformation, stability, and aggregation of monoclonal antibodies. Proteins 66, 954-962. Arakawa, T., Ejima, D., Tsumoto, K., Ishibashi, M., and Tokunaga, M. (2007). Improved performance of column chromatography by arginine: Dye-affinity chromatography. Protein Expr. Purif. 52, 410-414. Hsu, E., Osslund, T., Nybo, R., Chen, B. L., Kenney, W. C., Morris, C. F., Arakawa, T., and Narhi, L. O. (2006). Enhanced stability of recombinant keratinocyte growth factor by mutagenesis. Protein Eng. 19, 147-153. Arakawa, T., Ejima, D., Kita, Y., and Tsumoto, K. (2006). Small molecule pharmacological chaperones: From thermodynamic stabilization to pharmaceutical drugs. Biochim. Biophys. Acta 1764, 1677-1687. Arakawa, T., Philo, J. S., Ejima, D., Tsumoto, K., and Arisaka, F. (2006). Aggregation analysis of therapeutic proteins, part 1. Bioprocess International 4 (10), 42-49. [PDF] Ejima, D., Ono, K., Tsumoto, K., Arakawa, T., and Eto, Y. (2006). A novel "reverse screening" to identify refolding additives for activin-A. Protein Expr. Purif. 47, 45-51. Tsumoto, K., Ejima, D., Kita, Y., and Arakawa, T. (2005). Review: Why is arginine effective in suppressing aggregation? Protein Pept. Lett. 12, 613-619. Arakawa, T., Kita, Y., Ejima, D., Tsumoto, K., and Fukada, H. (2006). Aggregation suppression of proteins by arginine during thermal unfolding. Protein Pept. Lett. 13, 921-927. Ishibashi, M., Tsumoto, K., Ejima, D., Arakawa, T., and Tokunaga, M. (2005). Characterization of arginine as a solvent additive: a halophilic enzyme as a model protein. Protein Pept. Lett. 12, 649-653. Ishibashi, M., Tsumoto, K., Tokunaga, M., Ejima, D., Kita, Y., and Arakawa, T. (2005). Is arginine a protein-denaturant? Protein Expr. Purif. 42, 1-6. Ejima, D., Yumioka, R., Arakawa, T., and Tsumoto, K. (2005). Arginine as an effective additive in gel permeation chromatography. J. Chromatogr. A 1094, 49-55. Umetsu, M., Tsumoto, K., Nitta, S., Adschiri, T., Ejima, D., Arakawa, T., and Kumagai, I. (2005). Nondenaturing solubilization of beta2 microglobulin from inclusion bodies by L-arginine. Biochem. Biophys Res. Commun. 328, 189-197. Ejima, D., Yumioka, R., Tsumoto, K., and Arakawa, T. (2005). Effective elution of antibodies by arginine and arginine derivatives in affinity column chromatography. Anal. Biochem. 345, 250-257. Tsumoto, K., Umetsu, M., Kumagai, I., Ejima, D., Philo, J. S., and Arakawa, T. (2004). Role of arginine in protein refolding, solubilization, and purification. Biotechnol. Prog. 20, 1301-1308. Ishibashi, M., Arakawa, T., and Tokunaga, M. (2004). Facilitated folding and subunit assembly in Escherichia coli and in vitro of nucleoside diphosphate kinase from extremely halophilic archaeon conferred by amino-terminal extension containing hexa-His-tag. FEBS Lett. 570, 87-92. Tanaka, Y., Tsumoto, K., Umetsu, M., Nakanishi, T., Yasutake, Y., Sakai, N., Yao, M., Tanaka, I., Arakawa, T., and Kumagai, I. (2004). Structural evidence for guanidine-protein side chain interactions: crystal structure of CutA from Pyrococcus horikoshii in 3 M guanidine hydrochloride. Biochem. Biophys Res. Commun. 323, 185-191. French, D. L., Arakawa, T., and Li, T. S. (2004). Fourier transformed infrared spectroscopic investigation of protein conformation in spray-dried protein/trehalose powders. Biopolymers 73, 524-531. Arakawa, T., Philo, J. S., Tsumoto, K., Yumioka, R., and Ejima, D. (2004). Elution of antibodies from a Protein-A column by aqueous arginine solutions. Protein Expr. Purif. 36, 244-248. Tokunaga, H., Ishibashi, M., Arakawa, T., and Tokunaga, M. (2004). Highly efficient renaturation of β-lactamase isolated from moderately halophilic bacteria. FEBS Lett. 558, 7-12. Arakawa, T., Katsuyama, I., Kumagai, I., and Tsumoto, K. (2003). [A magic agent in protein refolding: arginine]. Tanpakushitsu Kakusan Koso 48, 2310-2317. Tsumoto, K., Umetsu, M., Kumagai, I., Ejima, D., and Arakawa, T. (2003). Solubilization of active green fluorescent protein from insoluble particles by guanidine and arginine. Biochem. Biophys. Res. Commun. 312, 1383-1386. Tsumoto, K., Ejima, D., Kumagai, I., and Arakawa, T. (2003). Practical considerations in refolding proteins from inclusion bodies. Protein Expr. Purif. 28, 1-8. Ishibashi, M., Sakashita, K., Tokunaga, H., Arakawa, T., and Tokunaga, M. (2003). Activation of halophilic nucleoside diphosphate kinase by a non-ionic osmolyte, trimethylamine N-oxide. J. Protein Chem. 22, 345-351. Arakawa, T. and Tsumoto, K. (2003). The effects of arginine on refolding of aggregated proteins: not facilitate refolding, but suppress aggregation. Biochem. Biophys. Res. Commun. 304, 148-152. Yokoyama, K., Ejima, D., Kita, Y., Philo, J. S., and Arakawa, T. (2003). Structure of folding intermediates at pH 4.0 and native state of microbial transglutaminase. Biosci. Biotechnol. Biochem. 67, 291-294. Arakawa, T. and Philo, J. S. (2002). Biophysical and biochemical analysis of recombinant proteins. In: Pharmaceutical Biotechnology, 2nd edition. D. J .A. Crommelin and R. D. Sindelar, eds. Taylor & Francis, London, pp. 25-51. Ishibashi, M., Arakawa, T., Philo, J.S., Sakashita, K., Yonezawa, Y., Tokunaga, H., and Tokunaga, M. (2002) Secondary and quaternary structural transition of the halophilic archaeon nucleoside diphosphate kinase under high- and low-salt conditions. FEMS Microbiol. Lett. 216, 235-241. Arakawa, T., Li, T., and Narhi, L. O. (2002). Recombinant production of native proteins from Escherichia coli. Pharm. Biotechnol. 13, 27-60. Toyoda, T., Arakawa, T., and Yamaguchi, H. (2002). N-glycans stabilize human erythropoietin through hydrophobic interactions with the hydrophobic protein surface: studies by surface plasmon resonance analysis. J. Biochem. (Tokyo) 131, 511-515. Kita, Y. and Arakawa, T. (2002). Salts and glycine increase reversibility and decrease aggregation during thermal unfolding of ribonuclease-A. Biosci. Biotechnol. Biochem. 66, 880-882. Li, T. S., Talvenheimo, J., Zeni, L., Rosenfeld, R., Stearns, G., and Arakawa, T. (2002). Changes in protein conformation and dynamics upon complex formation of brain-derived neurotrophic factor and its receptor: Investigation by isotope-edited Fourier transform IR spectroscopy. Biopolymers 67, 10-19. Li, T., Yamane, H., Arakawa, T., Narhi, L. O., and Philo, J. (2002). Effect of the intermolecular disulfide bond on the conformation and stability of glial cell line-derived neurotrophic factor. Protein Eng 15, 59-64. Arakawa, T. and Wen, J. (2001). Determination of carbohydrate contents from excess light scattering. Anal. Biochem. 299, 158-161. Tokunaga, M., Shiraishi, Y., Odachi, M., Mizukami, M., Tokunaga, H., Philo, J. S., Arakawa, T., Ishibashi, M., Tanaka, R., and Takagi, H. (2001). Molecular cloning of groESL locus, and purification and characterization of chaperonins, GroEL and GroES, from Bacillus brevis. Biosci. Biotechnol. Biochem. 65, 1379-1387. Arakawa, T., Philo, J. S., and Kita, Y. (2001). Kinetic and thermodynamic analysis of thermal unfolding of recombinant erythropoietin. Biosci. Biotechnol. Biochem. 65, 1321-1327. Wen, J., Zhang, M., Horan, T.P., Philo, J.S., Li, T.S., Wypych, J., Mendiaz, E.A., Langley, K.E., Aoki, K.H., Kuwamoto, M., Kita, Y., and Arakawa, T. (2001). Copper staining method for extracting biologically active proteins from native gels. Biosci. Biotechnol. Biochem. 65, 1315-1320. Narhi, L.O., Arakawa, T., Aoki, K., Wen, J., Elliott, S., Boone, T., and Cheetham, J. (2001). Asn to Lys mutations at three sites which are N-glycosylated in the mammalian protein decrease the aggregation of Escherichia coli-derived erythropoietin. Protein Eng. 14, 135-140. Arakawa, T., Prestrelski, S.J., Kenney, W.C., and Carpenter, J.F. (2001). Factors affecting short-term and long-term stabilities of proteins. Adv. Drug Deliv. Rev. 46, 307-326. Ishibashi, M., Tokunaga, H., Hiratsuka, K., Yonezawa, Y., Tsurumaru, H., Arakawa, T., and Tokunaga, M. (2001). NaCl-activated nucleoside diphosphate kinase from extremely halophilic archaeon, Halobacterium salinarum, maintains native conformation without salt. FEBS Lett. 493, 134-138. Toyoda, T., Itai, T., Arakawa, T., Aoki, K.H., and Yamaguchi, H. (2000). Stabilization of human recombinant erythropoietin through interactions with the highly branched N-glycans. J. Biochem. (Tokyo) 128, 731-737. Wato, S., Kamei, K., Arakawa, T., Philo, J.S., Wen, J., Hara, S., and Yamaguchi, H. (2000). A chimera-like alpha-amylase inhibitor suggesting the evolution of Phaseolus vulgaris alpha-amylase Inhibitor. J. Biochem. (Tokyo) 128, 139-144. Arakawa, T. and Kita, Y. (2000). Stabilizing effects of caprylate and acetyltryptophanate on heat- induced aggregation of bovine serum albumin. Biochim. Biophys. Acta 1479, 32-36. Arakawa, T. and Kita, Y. (2000). Protection of bovine serum albumin from aggregation by tween 80. J. Pharm. Sci. 89, 646-651. Wen, J. and Arakawa, T. (2000). Refractive index of proteins in aqueous sodium chloride. Anal. Biochem. 280, 327-329. Tokunaga, H., Hara, S., Arakawa, T., Ishibashi, M., Gupta, R.S., and Tokunaga, M. (1999). Identification and partial purification of DnaK homologue from extremely halophilic archaebacteria, Halobacterium cutirubrum. J. Protein Chem. 18, 837-844. Arakawa, T. and Philo, J.S. (1999). [Applications of Analytical Ultracentrifuge to Molecular Biology and Pharmaceutical Science]. Yakugaku Zasshi 119, 597-611. Arakawa,
T. and Kita, Y. (1999). Refractive index of proteins in organic solvents. Anal. Biochem.
271, 119-120. Caughey,
D. J., Narhi, L. O., Kita, Y., Meng, S. Y., Wen, D., Chen, W., Ratzkin, B. J.,
Fujimoto, J., Iwahara, T., Yamamoto, T., and Arakawa, T. (1999). Fractionation
of polyclonal antibodies to fragments of a neuroreceptor using three
increasingly chaotropic solvents. J.Chromatogr.B Biomed.Sci.Appl. 728,
49-57. Danilenko,
D. N., Montestruque, S., Philo, J. S., Li, T. S., Hill, D., Speakman, J., Bahru,
M., Zhang, M. S., Konishi, O., Itoh, N., Chirica, M., Delaney, J., Hernday, N.,
Martin, F., Hara, S., Talvenheimo, J., Narhi, L. O., and Arakawa, T. (1999).
Recombinant rat fibroblast growth factor-16: Structure and biological activity. Arch. Biochem. Biophys.
361, 34-46. Narhi, L.
O., Philo, J. S., Sun, B., Chang, B. S., and Arakawa, T. (1999). Reversibility
of heat-induced denaturation of the recombinant human megakaryocyte growth and
development factor. Pharm. Res. 16, 799-807. Haniu, M.,
Arakawa, T., Bures, E. J., Young, Y., Hui, J. O., Rohde, M. F., Welcher, A. A.,
and Horan, T. (1998). Human leptin receptor - Determination of disulfide
structure and N-glycosylation sites of the extracellular domain. J. Biol. Chem.
273, 28691-28699. Horan, T.
P., Simonet, L., Jacobsen, R., Mann, M., Haniu, M., Wen, J., Arakawa, T.,
Kuwamoto, M., and Martin, F. (1998). Coexpression of G-CSF with an
unglycosylated G-CSF receptor mutant results in secretion of a stable complex. Protein
Expr. Purif. 14, 45-53. Hu, M. C.,
Qiu, W. R., Wang, Y. P., Hill, D., Ring, B. D., Scully, S., Bolon, B., DeRose,
M., Luethy, R., Simonet, W. S., Arakawa, T., and Danilenko, D. M. (1998).
FGF-18, a novel member of the fibroblast growth factor family, stimulates
hepatic and intestinal proliferation. Mole. Cell. 18,
6063-6074. Koyama, A.
H., Arakawa, T., and Adachi, A. (1998). Acceleration of virus-induced apoptosis
by tumor necrosis factor. FEBS Letters 426, 179-182. Li, T.,
Narhi, L. O., Wen, J., Philo, J. S., Sitney, K., Inoue, J., Yamamoto, T., and
Arakawa, T. (1998). Interactions between NFkappaB and its inhibitor ikappaB:
biophysical characterization of a NFkappaB/ikappaB-alpha complex. J. Prot. Chem.
17, 757-763. Miyake,
A., Konishi, M., Martin, F. H., Hernday, N. A., Ozaki, K., Yamamoto, S., Mikami,
T., Arakawa, T., and Itoh, N. (1998). Structure and expression of a novel
member, FGF-16, of the fibroblast growth factor family. Biochem. Biophys. Res. Commun.
243, 148-152. Narhi, L.
O., Wypych, J., Li, T., Langley, K. E., and Arakawa, T. (1998). Changes in
conformation and stability upon SCF/sKit complex formation. J. Prot. Chem.
17 , 387-396. Osslund,
T. D., Syed, R., Singer, E., Hsu, E. W., Nybo, R., Chen, B. L., Harvey, T.,
Arakawa, T., Narhi, L. O., Chirino, A., and Morris, C. F. (1998). Correlation
between the 1.6 A crystal structure and mutational analysis of keratinocyte
growth factor. Protein Sci. 7, 1681-1690. Takahashi,
C., Sheng, Z., Horan, T. P., Kitayama, H., Maki, M., Hitomi, K., Kitaura, Y.,
Takai, S., Sasahara, R. M., Horimoto, A., Ikawa, Y., Ratzkin, B. J., Arakawa,
T., and Noda, M. (1998). Regulation of matrix metalloproteinase-9 and inhibition
of tumor invasion by the membrane-anchored glycoprotein RECK. Proc.Natl.Acad.Sci.U.S.A
95, 13221-13226. Tanaka,
R., Tokunaga, H., Hara, S., Arakawa, T., and Tokunaga, M. (1998). Expression and
purification of cytokine receptor homology domain of human granulocyte-colony
stimulating factor receptor in Escherichia coli . Bioscience,
Biotechnology and Biochemistry 62, 1809-1811. Horan, T.
P., Martin, F., Simonet, L., Arakawa, T., and Philo, J. S. (1997). Dimerization
of granulocyte-colony stimulating factor receptor: the Ig plus CRH construct of
granulocyte-colony stimulating factor receptor forms a 2:2 complex with a
ligand. J. Biochem. (Tokyo) 121, 370-375. Iwahara,
T., Fujimoto, J., Wen, D., Cupples, R., Bucay, N., Arakawa, T., Mori, S.,
Ratzkin, B., and Yamamoto, T. (1997). Molecular characterization of ALK, a
receptor tyrosine kinase expressed specifically in the nervous system. Oncogene
14, 439-449. Kendrick,
B. S., Chang, B. S., Arakawa, T., Peterson, B., Randolph, T. W., Manning, M. C.,
and Carpenter, J. F. (1997). Preferential exclusion of sucrose from recombinant
interleukin-1 receptor antagonist: Role in restricted conformational mobility
and compaction of native state. Proc. Natl. Acad. Sci. USA 94, 11917-11922. Kendrick,
B. S., Chang, B. S., Arakawa, T., Peterson, B., Randolph, T. W., Manning, M. C.,
and Carpenter, J. F. (1997). Preferential exclusion of sucrose from recombinant
interleukin-1 receptor antagonist: role in restricted conformational mobility
and compaction of native state. Proc.Natl.Acad.Sci.USA 94,
11917-11922. Kolvenbach,
C. G., Narhi, L. O., Philo, J. S., Li, T., Zhang, M., and Arakawa, T. (1997).
Granulocyte-colony stimulating factor maintains a thermally stable, compact,
partially folded structure at pH2. J.Pept.Res. 50, 310-318. Li, T.,
Horan, T. P., Osslund, T., Stearns, G., and Arakawa, T. (1997). Conformational
changes in G-CSF/Receptor complex as investigated by isotope-edited FTIR
spectroscopy. Biochemistry 36, 8849-8857. Liu, Y.
W., Chen, B. K., Chen, C. J., Arakawa, T., Yoshimoto, T., Yamamoto, S., and
Chang, W. C. (1997). Epidermal growth factor enhances transcription of human
arachidonate 12- lipoxygenase in A431 cells. Biochim.Biophys.Acta 1344,
38-46. Nakaguchi,
T., Arakawa, T., Philo, J. S., Wen, J., Ishimoto, M., and Yamaguchi, H. (1997).
Structural characterization of an a-amylase inhibitor from a wild common bean (Phaseolus
vulgaris): Insight into the common structural features of leguminous a-amylase
inhibitors. J. Biochem. (Tokyo) 121, 350-354. Narhi, L.
O., Caughey, D. J., Horan, T., Kita, Y., Chang, D., and Arakawa, T. (1997).
Effect of three elution buffers on the recovery and structure of monoclonal
antibodies. Anal. Biochem. 253, 236-245. Narhi, L.
O., Aoki, K. H., Philo, J. S., and Arakawa, T. (1997). Changes in conformation
and stability upon formation of complexes of erythropoietin (EPO) and soluble
EPO receptor. J. Prot. Chem. 16, 213-225. Narhi, L.
O., Caughey, D. J., Horan, T. P., Kita, Y., Chang, D., and Arakawa, T. (1997).
Fractionation and characterization of polyclonal antibodies using three
progressively more chaotropic solvents. Anal. Biochem. 253,
246-252. Narhi, L.
O., Rosenfeld, R., Shimamoto, G., Lee, R., Hawkins, N., Li, T., Philo, J. S.,
Wen, J., and Arakawa, T. (1997). Comparison of solution properties of human and
rat ciliary neurotrophic factor. J.Pept.Res. 50, 300-309. Rosenfeld,
R. D., Miller, J. A., Narhi, L. O., Hawkins, N., Katta, V., Lauren, S., Weiss,
M. A., and Arakawa, T. (1997). Putative folding pathway of insulin-like growth
factor-I. Arch. Biochem. Biophys. 342, 298-305. Wen, J.,
Arakawa, T., Wypych, J., Langley, K. E., Schwartz, M. G., and Philo, J. S.
(1997). Chromatographic determination of extinction coefficients of
non-glycosylated proteins using refractive index (RI) and UV absorbance (UV)
detectors: Applications for studying protein interactions by size exclusion
chromatography with light-scattering, UV, and RI detectors. In 'Techniques in
Protein Chemistry VIII.' (Ed D. R. Marshak.) pp. 113-119. (Academic Press: San
Diego.) Arakawa,
T., Li, T., Philo, J. S., Narhi, L. O., Horan, T. P., and Osslund, T. D. (1996).
Characterization of granulocyte-colony stimulating factor: structure and
interactions with its receptor. EOS J.Immunol.Immunopharmacol. 16,
35-40. Chang, B.
S., Beauvais, R. M., Arakawa, T., Narhi, L. O., Dong, A. C., Aparisio, D. I.,
and Carpenter, J. F. (1996). Formation of an active dimer during storage of
interleukin-1 receptor antagonist in aqueous solution. Biophysical Journal
71, 3399-3406. Chen, B.
L. and Arakawa, T. (1996). Stabilization of recombinant human keratinocyte
growth factor by osmolytes and salts. J. Pharm. Sci. 85,
419-422. Haniu, M.,
Horan, T., Arakawa, T., Le, J., Katta, V., Hara, S., and Rohde, M. F. (1996).
Disulfide structure and N-glycosylation sites of an extracellular domain
of granulocyte-colony stimulating factor receptor. Biochemistry 35,
13040-13046. Horan, T.
P., Wen, J., Narhi, L. O., Parker, V., Garcia, A., Arakawa, T., and Philo, J. S.
(1996). Dimerization of the extracellular domain of granulocyte-colony
stimulating factor receptor by ligand binding: A monovalent ligand induces 2:2
complexes. Biochemistry 35, 4886-4896. Hua, Q.
X., Narhi, L. O., Jia, W., Arakawa, T., Rosenfeld, R., Hawkins, N., Miller, J.
A., and Weiss, M. A. (1996). Native and non-native structure in a
protein-folding intermediate: spectroscopic studies of partially reduced IGF-I
and an engineered alanine model. Journal of Molecular Biology 259,
297-313. Kasahara,
K., Hayashi, K., Arakawa, T., Philo, J. S., Wen, J., Hara, S., and Yamaguchi, H.
(1996). Complete sequence, subunit structure, and complexes with pancreatic
alpha-amylase of an alpha-amylase inhibitor from Phaseolus vulgaris white kidney
beans. J. Biochem. (Tokyo) 120, 177-183. Kita, Y.,
Tseng, J., Horan, T. P., Wen, J., Philo, J. S., Chang, D., Ratzkin, B., Pacifici,
R., Brankow, D., Hu, S., Luo, Y., Wen, D., Arakawa, T., and Nicolson, M. (1996).
ErbB receptor activation, cell morphology changes, and apoptosis induced by
anti-Her2 monoclonal antibodies. Biochem. Biophys. Res. Commun. 226, 59-69. Narhi, L.
O., Philo, J. S., Li, T. S., Zhang, M., Samal, B., and Arakawa, T. (1996).
Induction of a-helix in the b-sheet protein tumor necrosis factor-a: Thermal- and trifluoroethanol-induced denaturation
at neutral pH. Biochemistry 35, 11447-11453. Narhi, L.
O., Philo, J. S., Li, T. S., Zhang, M., Samal, B., and Arakawa, T. (1996).
Induction of a-helix in the b-sheet protein tumor necrosis factor-a: Acid-induced denaturation. Biochemistry 35,
11454-11460. Niven, R.
W., Prestrelski, S. J., Treuheit, M. J., Ip, A. Y., and Arakawa, T. (1996).
Protein nebulization. 2. Stabilization of G-CSF to air-jet nubulization and the
role of protectants. Int.J.Pharm. 127, 191-201. Philo, J.
S., Aoki, K. H., Arakawa, T., Narhi, L. O., and Wen, J. (1996). Dimerization of
the extracellular domain of the erythropoietin (EPO) receptor by EPO: One
high-affinity and one low-affinity interaction. Biochemistry 35,
1681-1691. Samal, B.,
Boone, T., Karan, B., Chen, K., Sachdev, R., and Arakawa, T. (1996). Cloning and
expression of the gene encoding a novel proteinase from Tritirachium album
limber. Advances in Experimental Medicine and Biology 379, 95-104. Wen, J.,
Arakawa, T., Talvenheimo, J., Welcher, A. A., Horan, T. P., Kita, Y. A., Tseng,
J., Nicolson, M., and Philo, J. S. (1996). A light scattering/size exclusion
chromatography method for studying the stoichiometry of a protein-protein
complex. In 'Techniques in Protein Chemistry VII.' pp. 23-31. (Academic Press: Wen, J.,
Hsu, E., Kenney, W. C., Philo, J. S., Morris, C. F., and Arakawa, T. (1996).
Characterization of keratinocyte growth factor binding to heparin and dextran
sulfate. Arch. Biochem. Biophys. 332, 41-46. Wen, J.,
Arakawa, T., and Philo, J. S. (1996). Size-exclusion chromatography with on-line
light-scattering, absorbance, and refractive index detectors for studying
proteins and their interactions. Anal. Biochem. 240,
155-166. Zhang, M.
Z., Pikal, K., Nguyen, T., Arakawa, T., and Prestrelski, S. J. (1996). The
effect of the reconstitution medium on aggregation of lyophilized recombinant
interleukin-2 and ribonuclease A. Pharm. Res. 13,
643-646. Arakawa,
T., Horan, T. P., Leong, K., Prestrelski, S. J., Narhi, L. O., and Hu, S.
(1995). Structure and activity of granulocyte colony-stimulating factor derived
from CHO cells containing cDNA coding for alternatively spliced sequences. Arch. Biochem. Biophys.
316, 285-289. Arakawa,
T., Holst, P., Narhi, L. O., Philo, J. S., Wen, J., Prestrelski, S. J., Zhu, X.
T., Rees, D. C., and Fox, G. M. (1995). The importance of Arg40 and 45 in the
mitogenic activity and structural stability of basic fibroblast growth factor:
Effects of acidic amino acid substitutions. J. Prot. Chem. 14,
263-274. Haniu, M.,
Horan, T., Arakawa, T., Le, J., Katta, V., and Rohde, M. F. (1995).
Extracellular domain of granulocyte-colony stimulating factor receptor -
Interaction with its ligand and identification of a domain in close proximity of
ligand-binding region. Arch. Biochem. Biophys. 324,
344-356. Horan, T.
P., Wen, J., Arakawa, T., Liu, N., Brankow, D., Hu, S., Ratzkin, B., and Philo,
J. S. (1995). Binding of Neu differentiation factor with the extracellular
domain of Her2 and Her3. J. Biol. Chem. 270,
24604-24608. Ip, A. Y.,
Arakawa, T., Silvers, H., Ransone, C. M., and Niven, R. W. (1995). Stability of
recombinant consensus interferon to air-jet and ultrasonic nebulization. J. Pharm. Sci.
84, 1210-1214. Murray, H.
W., Hariprashad, J., Aguero, B., Arakawa, T., and Yeganegi, H. (1995).
Antimicrobial response of a T cell-deficient host to cytokine therapy: effect of
interferon-gamma in experimental visceral leishmaniasis in nude mice. J.Infect.Dis.
171, 1309-1316. Niven, R.
W., Ip, A. Y., Mittelman, S., Prestrelski, S. J., and Arakawa, T. (1995). Some
factors associated with the ultrasonic nebulization of proteins. Pharm. Res.
12, 53-59. Prestrelski,
S. J., Pikal, K. A., and Arakawa, T. (1995). Optimization of lyophilization
conditions for recombinant human interleukin-2 by dried-state conformational
analysis using fourier-transform infrared spectroscopy. Pharm. Res. 12, 1250-1259. Samal, B.
B., Arakawa, T., Boone, T. C., Jones, T., Prestrelski, S. J., Narhi, L. O., Wen,
J., Stearns, G. W., Crandall, C. A., and Pope, J. (1995). High level expression
of human leukemia inhibitory factor (LIF) from a synthetic gene in Escherichia
coli and the physical and biological characterization of the protein. Biochim.Biophys.Acta
1260, 27-34. Zhang, M.
Z., Wen, J., Arakawa, T., and Prestrelski, S. J. (1995). A new strategy for
enhancing the stability of lyophilized protein: The effect of the reconstitution
medium on keratinocyte growth factor. Pharm. Res. 12,
1447-1452. Arakawa,
T., Philo, J. S., and Kenney, W. C. (1994). Structure and solubility of
interleukin-2 in sodium dodecyl sulfate. International Journal of Peptide and
Protein Research 43, 583-587. Arakawa,
T., Haniu, M., Narhi, L. O., Miller, J. A., Talvenheimo, J., Philo, J. S.,
Chute, H. T., Matheson, C., Carnahan, J., Louis, J.-C., Yan, Q., Welcher, A. A.,
and Rosenfeld, R. (1994). Formation of heterodimers from 3 neurotrophins, nerve
growth- factor, neurotrophin-3, and brain-derived neurotrophic factor. J. Biol. Chem.
269, 27833-27839. Arakawa,
T., Wen, J., and Philo, J. S. (1994). Stoichiometry of heparin binding to basic
fibroblast growth factor. Arch. Biochem. Biophys. 308,
267-273. Chen, B.
L., Arakawa, T., Morris, C. F., Kenney, W. C., Wells, C. M., and Pitt, C. G.
(1994). Aggregation pathway of recombinant human keratinocyte growth factor and
its stabilization. Pharm. Res. 11, 1581-1587. Chen, B.
L., Arakawa, T., Hsu, E., Narhi, L. O., Tressel, T. J., and Chien, S. L. (1994).
Strategies to suppress aggregation of recombinant keratinocyte growth factor
during liquid formulation development. J. Pharm. Sci. 83, 1657-1661. Kenney, W.
C., Haniu, M., Herman, A. C., Arakawa, T., Costigan, V. J., Lary, J., Yphantis,
D. A., and Thomason, A. R. (1994). Formation of mitogenically active PDGF-B
dimer does not require interchain disulfide bonds. J. Biol. Chem. 269, 12351-12359. Kita, Y.,
Arakawa, T., Lin, T. Y., and Timasheff, S. N. (1994). Contribution of the
surface free energy perturbation to protein-solvent interactions. Biochemistry
33, 15178-15189. Philo, J.
S., Talvenheimo, J., Wen, J., Rosenfeld, R., Welcher, A. A., and Arakawa, T.
(1994). Interactions of neurotrophin-3 (NT-3), brain-derived neurotrophic factor
(BDNF), and the NT-3/BDNF heterodimer with the extracellular domains of the TrkB
and TrkC receptors. J. Biol. Chem. 269,
27840-27846. Prestrelski,
S. J., Arakawa, T., Duker, K., Kenney, W. C., and Narhi, L. O. (1994). The
conformational stability of a non-covalent dimer of a platelet- derived growth
factor-B mutant lacking the two cysteines involved in interchain disulfide
bonds. International Journal of Peptide and Protein Research 44,
357-363. Arakawa,
T., Horan, T. P., Narhi, L. O., Rees, D. C., Schiffer, S. G., Holst, P. L.,
Prestrelski, S. J., Tsai, L. B., and Fox, G. M. (1993). Production and
characterization of an analog of acidic fibroblast growth factor with enhanced
stability and biological activity. Protein Eng. 6, 541-546. Arakawa,
T., Hung, L., Pan, V., Horan, T. P., Kolvenbach, C. G., and Narhi, L. O. (1993).
Analysis of the heat-induced denaturation of proteins using temperature gradient
gel electrophoresis. Anal. Biochem. 208, 255-259. Arakawa,
T., Prestrelski, S. J., Kenney, W. C., and Carpenter, J. F. (1993). Factors
affecting short-term and long-term stabilities of proteins. Adv.Drug
Deliv.Rev. 10, 1-28. Arakawa,
T., Wen, J., and Philo, J. S. (1993). Densimetric determination of equilibrium
binding of sucrose octasulfate with basic fibroblast growth factor. J. Prot. Chem.
12, 689-693. Arakawa,
T., Prestrelski, S. J., Narhi, L. O., Boone, T. C., and Kenney, W. C. (1993).
Cysteine 17 of recombinant human granulocyte-colony stimulating factor is
partially solvent-exposed. J. Prot. Chem. 12,
525-532. Carpenter,
J. F., Prestrelski, S. J., and Arakawa, T. (1993). Separation of free. Arch. Biochem. Biophys.
303, 456-464. Carpenter,
J. F., Prestrelski, S. J., and Arakawa, T. (1993). Separation of freezing- and
drying-induced denaturation of lyophilized proteins using stress-specific
stabilization. I. Enzyme activity
and calorimetric studies. Arch. Biochem. Biophys. 303,
456-464. Haniu, M.,
Narhi, L. O., Arakawa, T., Elliott, S., and Rohde, M. F. (1993). Recombinant
human erythropoietin (rHuEPO): cross-linking with disuccinimidyl esters and
identification of the interfacing domains in EPO. Protein Sci. 2,
1441-1451. Hunt, P.,
Hokom, M. M., Hornkohl, A., Wiemann, B., Rohde, M. F., and Arakawa, T. (1993).
The effect of the platelet-derived glycosaminoglycan serglycin on in vitro
proplatelet-like process formation. Exp.Hematol. 21, 1295-1304. Hunt, P.,
Hokom, M. M., Wiemann, B., Leven, R. M., and Arakawa, T. (1993). Megakaryocyte
proplatelet-like process formation in vitro is inhibited by serum prothrombin, a
process which is blocked by matrix-bound glycosaminoglycans. Exp.Hematol.
21, 372-381. Kolvenbach,
C. G., Elliott, S., Sachdev, R., Arakawa, T., and Narhi, L. O. (1993).
Characterization of two fluorescent tryptophans in recombinant human
granulocyte-colony stimulating factor: comparison of native sequence protein and
tryptophan-deficient mutants. J. Prot. Chem. 12,
229-236. Lauren, S.
L., Arakawa, T., Stoney, K., and Rohde, M. F. (1993). Covalent dimerization of
recombinant human interferon-gamma. Arch. Biochem. Biophys. 306, 350-353. Miller, J.
A., Narhi, L. O., Hua, Q. X., Rosenfeld, R., Arakawa, T., Rohde, M., Prestrelski,
S., Lauren, S., Stoney, K. S., and Tsai, L. (1993). Oxidative refolding of
insulin-like growth factor 1 yields two products of similar thermodynamic
stability: a bifurcating protein-folding pathway. Biochemistry 32,
5203-5213. Narhi, L.
O., Kenney, W. C., Prestrelski, S. J., Arakawa, T., Lyons, D., Lary, J., and
Yphantis, D. A. (1993). Conformation of glutathione adduct and oxidized forms of
platelet- derived growth factor. International Journal of Peptide and Protein
Research 41, 8-14. Narhi, L.
O., Rosenfeld, R., Wen, J., Arakawa, T., Prestrelski, S. J., and Philo, J. S.
(1993). Acid-induced unfolding of brain-derived neurotrophic factor results in
the formation of a monomeric "A state". Biochemistry 32,
10819-10825. Narhi, L.
O., Rosenfeld, R., Talvenheimo, J., Prestrelski, S. J., Arakawa, T., Lary, J.
W., Kolvenbach, C. G., Hecht, R., Boone, T., Miller, J. A., and Yphantis, D. A.
(1993). Comparison of the biophysical characteristics of human brain- derived
neurotrophic factor, neurotrophin-3, and nerve growth factor. J. Biol. Chem.
268, 13309-13317. Narhi, L.
O., Hua, Q.-X., Arakawa, T., Fox, G. M., Tsai, L., Rosenfeld, R., Holst, P.,
Miller, J. A., and Weiss, M. A. (1993). Role of native disulfide bonds in the
structure and activity of insulin-like growth factor 1: Genetic models of
protein- folding intermediates. Biochemistry 32, 5214-5221. Niewold,
T. A., Gruys, E., Arakawa, T., Shirahama, T., and Kisilevsky, R. (1993).
Recombinant human tumour necrosis factor-alpha (rhTNF-alpha) and rhTNF- alpha
analogue enhance amyloid deposition in the Syrian hamster. Scand.J.Immunol.
37, 29-32. Niewold,
T. A., Arakawa, T., Kisilevsky, R., Shirahama, T., and Gruys, E. (1993). Human
recombinant TNF-alpha and poly-I poly-C induce SAA and enhance amyloidosis in
hamster. In 'Amyloid and amyloidosis, 1990; sixth international symposium on
amyloidosis.' (Ed J. B. Natvig.) pp. 68-70. (Kluwer Academic Publishers:
Norwell,MA.) Philo, J.
S., Rosenfeld, R., Arakawa, T., Wen, J., and Narhi, L. O. (1993). Refolding of
brain-derived neurotrophic factor from guanidine hydrochloride:
Kinetic trapping in a collapsed form which is incompetent for
dimerization. Biochemistry 32, 10812-10818. Prestrelski,
S. J., Arakawa, T., and Carpenter, J. F. (1993). Separation of freezing- and
drying-induced denaturation of lyophilized proteins using stress-specific
stabilization. II. Structural
studies using infrared spectroscopy. Arch. Biochem. Biophys. 303, 465-473. Prestrelski,
S. J., Tedeschi, N., Arakawa, T., and Carpenter, J. F. (1993).
Dehydration-induced conformational transitions in proteins and their inhibition
by stabilizers. Biophysical Journal 65, 661-671. Rosenfeld,
R., Philo, J. S., Haniu, M., Stoney, K., Rohde, M. F., Wu, G.-M., Narhi, L. O.,
Wong, C., Boone, T., Hawkins, N. N., Miller, J. M., and Arakawa, T. (1993).
Sites of iodination in recombinant human brain-derived neurotrophic factor and
its effect on neurotrophic activity. Protein Science 2, 1664-1674. Rosenfeld,
R. D., Noone, N. M., Lauren, S. L., Rohde, M. F., Narhi, L. O., and Arakawa, T.
(1993). Mutation of Arg55/56 to Leu55/Ala56 in insulin-like growth factor-I
results in two forms different in disulfide structure and native conformation
but similar under reverse-phase conditions. J. Prot. Chem. 12,
247-254. Samal, B.
B., Stearns, G. W., Boone, T. C., and Arakawa, T. (1993). Comparative analysis
of the effects of recombinant cytokines on the growth and differentiation of
ML-1, a human myelogenous leukemic cell line. Leuk.Res. 17,
299-304. Arakawa,
T. (1992). [Mechanism of stabilization of proteins by additives in freezing]. Tanpakushitsu
Kakusan Koso 37, 1517-1524. Arakawa,
T., Hung, L., and Narhi, L. O. (1992). Stability of fungal alpha-amylase in
sodium dodecylsulfate. J. Prot. Chem. 11, 111-117. Arakawa,
T., Hung, L., McGinley, M. G., Rohde, M. F., and Narhi, L. O. (1992). Induced
resistance of trypsin to sodium dodecylsulfate upon complex formation with
trypsin inhibitor. J. Prot. Chem. 11, 171-176. Arakawa,
T., Langley, K. E., Kameyama, K., and Takagi, T. (1992). Molecular weights of
glycosylated and nonglycosylated forms of recombinant human stem cell factor
determined by low- angle laser light scattering. Anal. Biochem. 203,
53-57. Carpenter,
J. F., Arakawa, T., and Crowe, J. H. (1992). Interactions of stabilizing
additives with proteins during freeze- thawing and freeze-drying. Dev.Biol.Stand.
74, 225-238. Dukor, R.
K., Pancoska, P., Keiderling, T. A., Prestrelski, S. J., and Arakawa, T. (1992).
Vibrational circular dichroism studies of epidermal growth factor and basic
fibroblast growth factor. Arch. Biochem. Biophys. 298,
678-681. Fox, G. M.
and Arakawa, T. (1992). Basic research of fibroblast growth factors. Biomedica
7, 472-477. Narhi, L.
O., Arakawa, T., McGinley, M. D., Rohde, M. F., and Westcott, K. R. (1992).
Circular dichroism of reduced and oxidized recombinant human epidermal growth
factor. International Journal of Peptide and Protein Research 39,
182-187. Prestrelski,
S. J., Arakawa, T., Wu, C.-S. C., O'Neal, K. D., Westcott, K. R., and Narhi, L.
O. (1992). Solution structure and dynamics of epidermal growth factor and
transforming growth factor a. J. Biol. Chem. 267 ,
319-322. Prestrelski,
S. J., Fox, G. M., and Arakawa, T. (1992). Binding of heparin to basic
fibroblast growth factor induces a conformational change. Arch. Biochem. Biophys.
293, 314-319. Arakawa,
T. and Timasheff, S. N. (1991). The interactions of proteins with salts, amino
acids and sugars at high concentration. Advances in comparative and
environmental physiology 19, 226-245. Arakawa,
T., Lazenby, K., Kolvenbach, C., Horan, T. P., and Narhi, L. O. (1991).
[Abnormal migration of subtilisin-Streptomyces subtilisin inhibitor
complex during sodium dodecylsulfate polyacrylamide gel electrophoresis. Agric.Biol.Chem.
55, 903-910. Arakawa,
T. and Narhi, L. O. (1991). Solvent modulation in hydrophobic interaction
chromatography. Biotechnol.Appl.Biochem. 13, 151-172. Arakawa,
T., Kita, Y. A., and Narhi, L. O. (1991). Protein-ligand interaction as a method
to study surface properties of proteins. Methods Biochem.Anal. 35,
87-125. Arakawa,
T., Kita, Y., and Carpenter, J. F. (1991). Protein--solvent interactions in
pharmaceutical formulations. Pharm. Res. 8, 285-291. Arakawa,
T., Yphantis, D. A., Lary, J. W., Narhi, L. O., Lu, H. S., Prestrelski, S. J.,
Clogston, C. L., Zsebo, K. M., Mendiaz, E. A., Wypych, J., and Langley, K. E.
(1991). Glycosylated and unglycosylated recombinant-derived human stem cell
factors are dimeric and have extensive regular secondary structure. J. Biol. Chem.
266, 18942-18948. Kolvenbach,
C. G., Langley, K. E., Strickland, T. W., Kenney, W. C., and Arakawa, T. (1991).
Densimetric determination of carbohydrate content in glycoproteins. J.Biochem.Biophys.Methods
23, 295-300. Narhi, L.
O., Stabinsky, Y., Levitt, M., Miller, L., Sachdev, R., Finley, S., Park, S.,
Kolvenbach, C., Arakawa, T., and Zukowski, M. (1991). Enhanced stability of
subtilisin by three point mutations. Biotechnol.Appl.Biochem. 13,
12-24. Narhi, L.
O., Kenney, W. C., and Arakawa, T. (1991). Conformational changes of recombinant
human granulocyte-colony stimulating factor induced by pH and guanidine
hydrochloride. J. Prot. Chem. 10, 359-367. Narhi, L.
O., Arakawa, T., Aoki, K. H., Elmore, R., Rohde, M. F., Boone, T., and
Strickland, T. W. (1991). The effect of carbohydrate on the structure and
stability of erythropoietin. J. Biol. Chem. 266,
23022-23026. Narhi, L.
O., Connor, J., Rohde, M. F., McGinley, M. G., and Arakawa, T. (1991).
Stoichiometric complexation of Streptomyces subtilisin inhibitor and subtilisin.
J. Prot. Chem. 10, 385-389. Prestrelski,
S. J., Arakawa, T., Kenney, W. C., and Byler, D. M. (1991). The secondary
structure of two recombinant human growth factors, platelet-derived growth
factor and basic fibroblast growth factor, as determined by Fourier-transform
infrared spectroscopy. Arch. Biochem. Biophys. 285,
111-115. Prestrelski,
S. J. and Arakawa, T. (1991). The solution structure and conformational dynamics
of tumor necrosis factor-alpha and a (Cys69----Asp; Cys101----Arg) analog as
examined by IR spectroscopy and hydrogen exchange. Protein Eng 4,
739-743. Zhu, X.,
Komiya, H., Chirino, A., Faham, S., Fox, G. M., Arakawa, T., Hsu, B. T., and
Rees, D. C. (1991). Three-dimensional structures of acidic and basic fibroblast
growth factors. Science 251,
90-93. Arakawa,
T., Carpenter, J. F., and Crowe, J. H. (1990). Basis for toxicity of certain
cryoprotectants: a hypothesis. Cryobiology 27, 401-415. Arakawa,
T. and Horan, T. P. (1990). [Thermal denaturation of subtilisin-SSI complex
analyzed by SDS-PAGE. Agric.Biol.Chem. 54, 563-565. Arakawa,
T., Hsu, Y. R., Narachi, M. A., Herrera, C., Rohde, M. F., and Hennigan, P.
(1990). Reversibility of acid denaturation of recombinant interferon-gamma. Biopolymers
29, 1065-1068. Arakawa,
T., Visger, J. V., McGinley, M., Rohde, M. F., Fox, G. M., and Narhi, L. O.
(1990). Alteration in folding efficiency and conformation of recombinant human
tumor necrosis factor-alpha by replacing cysteines 69 and 101 with aspartic acid
69 and arginine 101. Protein Eng 3, 721-724. Arakawa,
T., Horan, T. P., McGinley, M., and Rohde, M. F. (1990). Effect of
amino-terminal processing by Staphylococcus aureus V-8 protease on activity and
structure of recombinant human interferon- gamma. J.Interferon Res. 10,
321-329. Arakawa,
T., Bhat, R., and Timasheff, S. N. (1990). Preferential interactions determine
protein solubility in three- component solutions: the MgCl2 system. Biochemistry
29, 1914-1923. Arakawa,
T., Bhat, R., and Timasheff, S. N. (1990). Why preferential hydration does not
always stabilize the native structure of globular proteins. Biochemistry
29,
1924-1931. Carpenter,
J. F., Crowe, J. H., and Arakawa, T. (1990). Comparison of solute-induced
protein stabilization in aqueouis solution and in the frozen and dried states. J.Dairy
Sci. 73, 3627-3636. Elliott,
S., Fagin, K. D., Narhi, L. O., Miller, J. A., Jones, M., Koski, R., Peters, M.,
Hsieh, P., Sachdev, R., Rosenfeld, R. D., Arakawa, T., and Rohde, M. (1990).
Yeast-derived recombinant human insulin-like growth factor I: production,
purification, and structural characterization. J. Prot. Chem. 9, 95-104. Kita, Y.,
Rohde, M. F., Arakawa, T., Fagin, K. D., Fish, E. N., and Banerjee, K. (1990).
Characterization of a polyethylene glycol conjugate of recombinant human
interferon-gamma. Drug Des Deliv. 6, 157-167. Kolvenbach,
C. G., Narhi, L. O., Lazenby, K., Samal, B., and Arakawa, T. (1990). Comparative
study on proteinase R, T, and K from Tritirachiam album limber. International
Journal of Peptide and Protein Research 36, 387-391. Samal, B.,
Stearns, G., Crandall, C., Arakawa, T., and Boone, T. (1990). Identification of
interleukin 6 as a synergistic factor for the differentiation-inducing effect of
TNF on leukemic ML-1 cells. Leuk.Res. 14, 575-580. Arakawa,
T., Narachi, M. A., Hsu, Y. R., Everett, R. R., Lai, P. H., and Fish, E. N.
(1989). The effect of C-terminal processing on the activity of human interferon-
gamma. Drug Des Deliv. 4, 217-225. Arakawa,
T., Hsu, Y. R., Schiffer, S. G., Tsai, L. B., Curless, C., and Fox, G. M.
(1989). Characterization of a cysteine-free analog of recombinant human basic
fibroblast growth factor. Biochem. Biophys. Res. Commun. 161, 335-341. Arakawa,
T. (1989). The stabilization of beta-lactoglobulin by glycine and NaCl. Biopolymers
28, 1397-1401. Narhi, L.
O. and Arakawa, T. (1989). Sodium dodecyl sulfate polyacrylamide gel
electrophoresis as a method for studying the stability of subtilisin. Biochim.Biophys.Acta
990, 144-149. Narhi, L.
O., Kita, Y., and Arakawa, T. (1989). Hydrophobic interaction chromatography in
alkaline pH. Anal. Biochem. 182, 266-270. Narhi, L.
O., Rhode, M. F., Hunt, P., and Arakawa, T. (1989). The limited proteolysis of
tumor necrosis factor-alpha. J. Prot. Chem. 8,
669-677. Timasheff,
S. N. and Arakawa, T. (1989). Stabilization of protein structure by solvents. In
'Protein structure, a practical approach.' (Ed T. E. Creighton.) pp. 311-345. Ward, L.
D. and Arakawa, T. (1989). Stimulation of microtubule assembly by recombinant
human interferon- alpha and interferon-gamma. Biochim.Biophys.Acta 1012,
317-319. Arakawa,
T. and Kenney, W. C. (1988). Secondary structure of interleukin-2(Ala125) in
unfolded state. International Journal of Peptide and Protein Research 31,
468-473. Fish, E.
N., Banerjee, K., Arakawa, T., and Stebbing, N. (1988). Structure/function
studies on recombinant human gamma interferon. Drug Des Deliv. 2,
191-206. Fox, G.
M., Schiffer, S. G., Rohde, M. F., Tsai, L. B., Banks, A. R., and Arakawa, T.
(1988). Production, biological activity, and structure of recombinant basic
fibroblast growth factor and an analog with cysteine replaced by serine. J. Biol. Chem.
263, 18452-18458. Narhi, L.
O., Zukowski, M., and Arakawa, T. (1988). Stability of aprA-subtilisin in sodium
dodecyl sulfate. Arch. Biochem. Biophys. 261,
161-169. Timasheff,
S. N. and Arakawa, T. (1988). Mechanism of protein precipitation and
stabilization by co-solvents. J.Crystal Growth 90, 39-46. Arakawa,
T., Hsu, Y. R., Toth, E., and Stebbing, N. (1987). The antiviral activity of
recombinant human tumor necrosis factor-alpha. J.Interferon Res. 7,
103-105. Arakawa,
T. (1987). Effect of cosolvents on solubility of protein in equilibrium between
different states. Biopolymers 26, 45-57. Arakawa,
T. and Yphantis, D. A. (1987). Molecular weight of recombinant human tumor
necrosis factor-alpha. J. Biol. Chem. 262,
7484-7485. Arakawa,
T., Hsu, Y. R., and Yphantis, D. A. (1987). Acid unfolding and self-association
of recombinant Escherichia coli derived human interferon gamma. Biochemistry
26, 5428-5432. Arakawa,
T. and Timasheff, S. N. (1987). Abnormal solubility behavior of
beta-lactoglobulin: salting-in by glycine and NaCl. Biochemistry 26,
5147-5153. Davis, J.
M., Narachi, M. A., Alton, N. K., and Arakawa, T. (1987). Structure of human
tumor necrosis factor alpha derived from recombinant DNA. Biochemistry 26,
1322-1326. Davis, J.
M., Arakawa, T., Strickland, T. W., and Yphantis, D. A. (1987). Characterization
of recombinant human erythropoietin produced in Chinese hamster ovary cells. Biochemistry
26, 2633-2638. Davis, J.
M., Narachi, M. A., Levine, H. L., Alton, N. K., and Arakawa, T. (1987).
Conformation and stability of two recombinant human interferon-alpha analogs. International
Journal of Peptide and Protein Research 29, 685-691. Narachi,
M. A., Davis, J. M., Hsu, Y. R., and Arakawa, T. (1987). Role of single
disulfide in recombinant human tumor necrosis factor- alpha. J. Biol. Chem.
262 , 13107-13110. Narhi, L.
O. and Arakawa, T. (1987). Dissociation of recombinant tumor necrosis
factor-alpha studied by gel permeation chromatography. Biochem. Biophys. Res. Commun.
147, 740-746. Yphantis,
D. A. and Arakawa, T. (1987). Sedimentation equilibrium measurements of
recombinant DNA derived human interferon gamma. Biochemistry 26,
5422-5427. Arakawa,
T., Parker, C. G., and Lai, P. H. (1986). Sites of phosphorylation in
recombinant human interferon-gamma. Biochem. Biophys. Res. Commun. 136, 679-684. Arakawa,
T., Hsu, Y. R., Parker, C. G., and Lai, P. H. (1986). Role of polycationic
C-terminal portion in the structure and activity of recombinant human
interferon-gamma. J. Biol. Chem. 261, 8534-8539. Arakawa,
T. (1986). Thermodynamic analysis of the effect of concentrated salts on protein
interaction with hydrophobic and polysaccharide columns. Arch. Biochem. Biophys.
248, 101-105. Arakawa,
T., Boone, T., Davis, J. M., and Kenney, W. C. (1986). Structure of unfolded and
refolded recombinant derived [Ala125]interleukin 2. Biochemistry 25,
8274-8277. Arakawa,
T. (1986). Calculation of the partial specific volumes of proteins in
concentrated salt, sugar, and amino acid solutions. J. Biochem. (Tokyo) 100, 1471-1475. Arakawa,
T., Hsu, Y. R., Chang, D., Stebbing, N., and Altrock, B. (1986). Structure and
activity of glycosylated human interferon-gamma. J.Interferon Res. 6,
687-695. Hsu, Y.
R., Narachi, M., Davis, J. M., Hennigan, P., Goldman, R. A., Geis, A., Carter,
M., Stebbing, N., Alton, N. K., and Arakawa, T. (1986). Conformation and
biological activity of TNF-alpha and TNF-alpha analogs. Lymphokine
Res. 5 Suppl 1, S133-S137. Hsu, Y.
R., Ferguson, B., Narachi, M., Richards, R. M., Stabinsky, Y., Alton, N. K.,
Stebbing, N., and Arakawa, T. (1986). Structure and activity of recombinant
human interferon-gamma analogs. J.Interferon Res. 6, 663-670. Lai, P.
H., Everett, R., Wang, F. F., Arakawa, T., and Goldwasser, E. (1986). Structural
characterization of human erythropoietin. J. Biol. Chem. 261, 3116-3121. Arakawa,
T. and Frieden, C. (1985). The use of the fluorescence photobleaching recovery
technique to study the self-assembly of tubulin. Anal. Biochem. 146,
134-142. Arakawa,
T. and Timasheff, S. N. (1985). The stabilization of proteins by osmolytes. Biophysical
Journal 47, 411-414. Arakawa,
T. and Goddette, D. (1985). The mechanism of helical transition of proteins by
organic solvents. Arch. Biochem. Biophys. 240,
21-32. Arakawa,
T., Alton, N. K., and Hsu, Y. R. (1985). Preparation and characterization of
recombinant DNA-derived human interferon-gamma. J. Biol. Chem. 260, 14435-14439. Arakawa,
T. and Timasheff, S. N. (1985). Mechanism of poly(ethylene glycol) interaction
with proteins. Biochemistry 24, 6756-6762. Arakawa,
T. and Timasheff, S. N. (1985). Theory of protein solubility. Methods in
Enzymology 114, 49-77. Arakawa,
T. (1985). The mechanism of increased elution volume of proteins by polyethylene
glycol. Anal. Biochem. 144, 267-268. Arakawa,
T. (1985). [Solvation and properties of proteins]. Tanpakushitsu Kakusan Koso
30, 103-111. Arakawa,
T. and Timasheff, S. N. (1985). Calculation of the partial specific volume of
proteins in concentrated salt and amino acid solutions. Methods in Enzymology
117, 60-65. Hsu, Y. R.
and Arakawa, T. (1985). Structural studies on acid unfolding and refolding of
recombinant human interferon gamma. Biochemistry 24, 7959-7963. Arakawa,
T. and Timasheff, S. N. (1984). Mechanism of protein salting in and salting out
by divalent cation salts: balance between hydration and salt binding. Biochemistry
23, 5912-5923. Arakawa,
T. and Timasheff, S. N. (1984). Protein stabilization and destabilization by
guanidinium salts. Biochemistry 23, 5924-5929. Arakawa,
T. and Frieden, C. (1984). Interaction of microtubule-associated proteins with
actin filaments. Studies using the fluorescence-photobleaching recovery
technique. J. Biol. Chem. 259, 11730-11734. Arakawa,
T. and Timasheff, S. N. (1984). On protein precipitants. Seibutsubutsuri
24,
29-39. Arakawa,
T. and Timasheff, S. N. (1984). The mechanism of action of Na glutamate, lysine
HCl, and piperazine- N,N'-bis(2-ethanesulfonic acid) in the stabilization of
tubulin and microtubule formation. J. Biol. Chem. 259,
4979-4986. Arakawa,
T. and Timasheff, S. N. (1983). Preferential interactions of proteins with
solvent components in aqueous amino acid solutions. Arch. Biochem. Biophys.
224, 169-177. Arakawa,
T. and Timasheff, S. N. (1982). Stabilization of protein structure by sugars. Biochemistry
21, 6536-6544. Arakawa,
T. and Timasheff, S. N. (1982). Preferential interactions of proteins with salts
in concentrated solutions. Biochemistry 21, 6545-6552. Arakawa,
T. and Timasheff, S. N. (1982). [Mechanism of stabilization of proteins by
glycerol and sucrose]. Seikagaku 54, 1255-1259. Arakawa,
T. and Timasheff, S. N. (1982). [On protein-structure stabilizing solvent]. Seikagaku
54, 1307-1310. Timasheff,
S. N., Arakawa, T., Inoue, H., Gekko, K., Gorbunoff, M. J., Lee, J. C., Na, G.
C., Pitts, E. P., and Prakashi, V. (1981). The role of solvation in protein
structure stabilization and unfolding. Z.Physiol.Chem. 361, 1996. Arakawa,
T., Yoshida, M., Morishita, H., and Yonezawa, D. (1977). [Relation between
aggregation behavior of glutenin and its polypeptide composition]. Agric.Biol.Chem.
41, 95-101. Arakawa,
T. (1976). [Comparison of aggregation behavior of glutens from various wheat
flours]. New Food Ind. 18, 57-66. Arakawa,
T., Morishita, H., and Yonezawa, D. (1976). [Aggregation behaviors of glutens,
glutenins and gliadins from various sources]. Agric.Biol.Chem. 40,
1217-1220. Arakawa,
T., Matsumoto, S., and Yonezawa, D. (1975). [A study on the applicability of a
proposed equation describing the turbidity change due to aggregation]. Nippon
Eiseigaku Kaishi 48, 701-705. Arakawa,
T., Matsumoto, S., and Yonezawa, D. (1974). [Determination of aggregation
velocity of wheat gluten particles by turbidimetry]. Nippon
Noegeikagaku Kaishi 48, 255-259. Arakawa,
T. and Yonezawa, D. (1974). [Compositional difference of wheat flour proteins in
relation to their aggregation behavior]. Agric.Biol.Chem. 39,
2123-2128. Hamauzu,
Z., Arakawa, T., and Yonezawa, D. (1972). [Molecular weights of glutenin- and
gliadin-polypeptides estimated by SDS-polyacrylamide gel electrophoresis]. Agric.Biol.Chem.
36, 1829-1830.
|
|
All text, images, and downloadable documents are © copyright 2000-2008, Alliance Protein Laboratories Inc. |